The Role of Adiponectin in Breast cancer: The mechanism and action
Abstract
Adiponectin is one of the most important members of adipokine family which is widely synthesized and secreted by adipose tissue. The action of adiponectin is via binding to main receptors. It has several actions including regulation of glucose level, lipid homeostasis and reproductive system. Adiponectin can also influence vascular endothelium via preventing the migration of monocytes. The role of adiponectin has been detected in progression of certain cancers associated with obesity. Obesity is a risk factor for breast cancer and develops the progression of breast cancer, since adipocytokines are produced exclusively by adipose tissue and may influence the association between obesity and breast cancer risk. Therefore, it seems that obesity can play important role in the pathogenesis of breast cancer. The mechanism of adiponectin action in breast cancer is currently unknown. It seems that adiponectin motivates the sensitivity of peripheral tissue to insulin. Insulin can motivate the proliferation of breast cancer cells via signaling through insulin and insulin –like growth factor (IGF-1) receptors. Also insulin may upregulate a potent angiogenic agent including vascular endothelial growth factor (VEGF) expression that is secreted by breast cancer cells.-Mohan reddy Nalabolu, Kalyani Palasamudram, Kaiser Jamil. Adiponectin and Leptin Molecular Actions and Clinical Significance in Breast Cancer. IJHOSCR 2014; 8(1): 1-10
- Somayeh Bohlouli D.V.M, Mozafar Khazaei, , Masoud Teshfam, , Hosein Hassanpour. Adiponectin Effect on The Viability of Human Endometrial Stromal Cells and mRNA Expression of Adiponectin Receptors. International Journal of Fertility and Sterility 2013; 7(1): 43-48
-Maria Dalamaga, Vassiliki Koumaki. Adiponectin and cancer. Atlas Genet Cytogenet Oncol Haematol. 2014; 18(5): 361-367
-Katherine Robinson , John Prins , Bala Venkatesh. Clinical review: Adiponectin biology and its role in inflammation and critical illness. Critical Care 2011; 15 :221
-Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF: A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem
, 270: 26746-26749
-Enrique Z Fisman, Alexander Tenenbaum. Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease? ardiovascular Diabetology 2014, 13 :103
-Maiad-Fernandes T, Roncon-Albuquerque R Jr, Leite-Moreira AF: Cardiovascular actions of adiponectin: pathophysiologic implications. Rev Port Cardiol
, 27: 1431- 1449
-Silva TE, Colombo G, Schiavon LL: Adiponectin: A multitasking player in the field of liver diseases. Diabetes Metab 2014, 40: 95 – 107
-Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.
Biochem Biophys Res Commun 1999;257:79–83.
-Saito K, Tobe T, Minoshima S, Asakawa S, Sumiya J, Yoda M, Nakano Y, Shimizu N, Tomita M: Organization of the gene for gelatin-binding protein (GBP28).
Gene 1999, 229: 67-73
-Chun-Ying Lee, Chien-Hung Lee, Sharon Tsai, Chia-Tsuan Huang. Association between serum leptin and adiponectin levels with risk of insulin resistance and impaired glucose tolerance in non diabetic women. Kaohsiung J Med Sci March 2009; 25 ( 3): 116-126
-Maeda K, Okubo K, Shimomura I, et al. cDNA cloning and expression of a novel adipose specific collagenlike
factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res 1996;221:286–9.
-Andrea Bianco, Gennaro Mazzarella , Viviana Turchiarelli, Ersilia Nigro. Adiponectin: An Attractive Marker for Metabolic Disorders in Chronic Obstructive Pulmonary Disease (COPD). Nutrients 2013;5: 4115-4125
-D. Dranka Bojorwska, A. Lekstan E, M. Olakowski , B. Jablonska, A. Lewinski, et al. The assessment of serum concentration of adiponectin, leptin and serum carbohydrate antigen-19.9 in patients with pancreatic cancer and chronic pancreatitis. JOURNAL OF Physiology and Pharmacology 2015, 66, 5, 653-663
-Sulistyoningrum DC, Gasevic D, Lear SA, Ho J, Mente A, Devlin AM: Total and high molecular weight adiponectin and ethnic-specific differences in adiposity and insulin resistance: a cross-sectional study. Cardiovasc Diabetol 2013; 12: 170.
-. Hajer GR, Van Haeften TW, Visseren FL: Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J
, 29: 2959 – 2971.
-. Baars T, Konorza T, Kahlert P, Möhlenkamp S, Erbel R, Heusch G, Kleinbongard P: Coronary aspirate TNF α reflects saphenous vein bypass graft restenosis risk in diabetic patients. Cardiovasc Diabetol 2013, 12: 12
-Jiaxiang Ye, Zhongguo Liang, Qian Liang, Jinyan Zhang, Sufei Mao. Adiponectin is associated with poor prognosis in carcinoma patients: evidence from a meta-analysis. Lipids Health Dis. 2015; 14: 154.
-Ahmed SD, Khanam A, Sultan N, Idrees F, Akhter N. Serum Adiponectin Level Association with Breast Cancer Risk: Evidence from a Case-Control Study. Asian Pac J Cancer Prev. 2015;16(12):4945-8.
-I Kelesidis, T Kelesidis,CS Mantzoros. Adiponectin and cancer: a systematic review. British Journal of Cancer 2006; 94: 1221 – 1225
-Ukkola O, Santaniemi M. Adiponectin: a link between excess adiposity and associated comorbidities? J Mol Med 2002;80:696–702.
-Matsuzawa Y, Shimomura I, Kihara S, et al. Importance of adipocytokines in obesity-related diseases. Horm Res 2003;60 Suppl 3:56–9.
-D. Housa, Z. Vernerova, , J. Heracek, B. Prochazka, P. cechak. Adiponectin as a Potential Marker of Prostate Cancer Progression: Studies in Organ-Confined and Locally Advanced Prostate Cancer. Physiol. Res. 2008; 57: 451-458
-ME Grossmann, KJ Nkhata, NK Mizuno, A Ray . MP Cleary. Effects of adiponectin on breast cancer cell growth and signaling. British Journal of Cancer 2008; 98, 370 – 379
- Loredana Mauro, Giuseppina Daniela Naimo, Emilia Ricchio, Maria Luisa Panno, Sebastiano Andò. Cross-Talk between Adiponectin and IGF-IR in Breast Cancer. Front Oncol. 2015; 5: 157.
| Files | ||
| Issue | Vol 8 No 3 (2016) | |
| Section | Reviews | |
| Keywords | ||
| Adiponectin breast cancer mechanism action | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
